Rituximab in childhood systemic lupus erythematosus refractory to conventional immunosuppression: Ca...
Rituximab in childhood systemic lupus erythematosus refractory to conventional immunosuppression: Case report
About this item
Full title
Author / Creator
Publisher
Germany: Springer Nature B.V
Journal title
Language
English
Formats
Publication information
Publisher
Germany: Springer Nature B.V
Subjects
More information
Scope and Contents
Contents
Rituximab, a chimeric monoclonal antibody specific for human CD20, has recently been used for the treatment of autoimmune diseases. A 14-year-old patient with severe systemic lupus erythematosus (SLE) and class IV glomerulonephritis presented with immunologic and clinical resistance to conventional immunosuppressive therapy for 10 months after diag...
Alternative Titles
Full title
Rituximab in childhood systemic lupus erythematosus refractory to conventional immunosuppression: Case report
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_67825311
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67825311
Other Identifiers
ISSN
0931-041X
E-ISSN
1432-198X
DOI
10.1007/s00467-004-1760-1
